Saatja: Young Hun Ji <
[email protected]>
Saadetud: 05.11.2020 16:42
Adressaat: Tanel Kiik <
[email protected]>
Koopia: SM Info <
[email protected]>
Teema: Introducing our novel thermochromic medical device designed to
combat COVID-19
Dear Mr. Tanel Kiik,
My name is Young Hun Ji, and I am the EU Managing Director of Puritech, a
tech company based in South Korea. I am writing to introduce to you our
medical device, the PuriBAND, which is a thermochromic plaster that
immediately detects and visually indicates changes in the wearers body
temperature. I am reaching out to you specifically, as I am confident
that PuriBAND usage could dramatically enhance Estonias COVID-19
management and prevention efficacy.
The PuriBAND functions as follows: It is essentially a small round
sticker, applied to the skins surface (e.g., on the back of ones hand or
wrist), which then turns color in response to significant changes in body
temperature. Between the normal temperature range of 35°C and below
37.5°C, the PuriBAND will show a color between brown and green. At
temperatures approaching 37.5°C and above, however, the PuriBAND will
turn yellow. Hence, it can be used to visually alert users of a feverthe
most common symptom of COVID-19.
The PuriBAND is an excellent first-line defense against COVID-19 for two
reasons.
First, the PuriBAND is highly versatile and resource-efficient. It
enables constant temperature monitoring of a large number of individuals
with minimal effort and virtually zero disruptions during work or other
daily activities. It is thus effective in any setting where adequate
social distancing measures and frequent body temperature checks are not
easily implementable. This includes hospitals and care homes, which
accommodate the elderly and other risk group members; schools,
kindergartens, and daycare centers, where large groups of young children
congregate; and airports, where travelers and essential workers with a
fever need to be quickly identified and set aside for further medical
examination. In all of these settings, the PuriBAND makes body temperature
monitoring of large groups of people practically viable and time- and
cost-efficient.
Second, the PuriBAND has extremely high thermochromic precision and
responsiveness. In thermochromic materials, sensitivity to temperature
change is determined by the size of the microcapsules containing the
thermochromic dye. At Puritech, we utilize state-of-the-science
technology to manufacture extremely fine thermochromic microcapsules with
a diameter between 1 and 6 micrometers. This makes the PuriBAND more
sensitive to temperature changes compared to other, similar products
using thermochromic materials.
Against the backdrop of the COVID-19 outbreak, PuriBAND demand and usage
has surged in South Korea and other countries such as Japan and the U.S.,
and this has prompted us to begin mass production. This year, we obtained
certifications of FDA registration and CE marking for the PuriBAND.
Additionally, we obtained certifications for ISO 13485 (which tests
compliance with requirements regarding the design and manufacture of
medical devices) and ISO 10993 (which involves a series of tests
evaluating biocompatibility of medical devices to minimize biological
risk).
I would like to urge you to consider incorporating the PuriBAND into
Estonias multi-faceted strategy to eradicate COVID-19. I am confident
that PuriBAND usage would help protect the lives of Estonias residents,
and, furthermore, enable Estonian organizational bodies to better
optimize other COVID-19 management efforts and resource allocations.
Please let me know if you have any questions or wish to know more about
the PuriBAND or Puritech. I will be happy to provide further information.
You may also visit our website at . Thank you so much for your time.
Kind regards,
Young Hun Ji
Young Hun Ji, Ph.D.
EU Managing Director
Puritech
Sent from for Windows 10